ZGNX - Zogenix: Buying Opportunity
Thesis Summary
Zogenix, Inc. (ZGNX) is a pharmaceutical company that develops and commercializes therapies for rare diseases. Recently, some “disappointing” data on Fintepla sent the stock tumbling over 30%. However, I believe that the market has overreacted to the results, which, in any case, won’t stop Fintepla from reaching the market. Zogenix is now ready to begin selling and has licensing and production agreements. Furthermore, by this quarter, we could also see Fintepla reach the European market. Therefore, at the current price, I believe Zogenix offers a buying opportunity.
Company Overview
Zogenix, formerly